Josh Uppal

Doctor of Medicine,  Toronto General - University Health Network 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Journal Manuscript Pharma-CRO-Device Case Consulting Scientific Writing

Areas Of Interest

Tight Junction Protein ZO-1 Genetic Databank Fluorouracil RNA Isoforms Chemotactic Factors, Macrophage Arsenolite Hydrochloride, Amprolium Zinc Oxide Imidodipeptidase Deficiencies Human Connectome Human Chorionic Gonadotropin, beta Subunit Goiters, Endemic Social Control Policies Pharmacy, Online Disodium Salt, SITS Trauma, Penetrating Head Medical Faculty Salagen Psychological Identification Blood-Pool Scintigraphy Rights, Patients' Polymorphisms, Crystallization Factors, Peptide Initiation Controlled-Release Preparations Chains, Respiratory Artery, External Carotid p115 RhoGEF Area, Orbital Estimates, Maximum Likelihood Fructose 1,6 Diphosphatase Deficiency Savanna Chrysaora fuscescens Glyburide Spectroscopy, Fourier Transform Infrared Proteins, CUGBP Models, Logit Starch Gel Electrophoresis Feedbacks, Sensorimotor

Professional Narrative

Dr. Josh Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2002
Senior Director, Mayo Clinic 1998

Education

Bachelor of science in nursing, Baylor College 2010
Master of Science in physician assistant, Perelman School of Medicine 2001

Referees

Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02